Original Publication Date: 2 January, 2014
Publication / Source: Future Oncology
Authors: Natalie Turner1, Elena Zafarana1, Dimitri Becheri1, Giuseppe Mottino2 & Laura Biganzoli
Management of older breast cancer patients is challenging due to a lack of good quality evidence regarding the role of adjuvant chemotherapy. Older women can benefit as much from adjuvant chemotherapy as younger women, although they have an increased risk of toxicities. Decisions regarding adjuvant chemotherapy should be made based on tumor biology and biological age, rather than chronological age.